Principal Investigator
Alejandra Perez
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20230730
Clinical Trial Summary
A Phase III, multicenter, open-label study of ribociclib vs. palbociclib in patients with advanced hormone receptor-positive/HER2-negative/HER2- Enriched (HER2-E) breast cancer - HARMONIA trial
Phase
Phase III
Funding Agency/Sponsor
Industrial
Disease
Breast Cancer
Contact Information
Phone Number
305-243-2647